Protecting Public Health
Providing Assurance, Combating Corruption, Responding to the Trade in Illicit Medicines and Health Products
GHAP plays an established role in efforts to protect public health in low and middle-income countries (LMIC) serving as an assurance partner for donors and aid agencies, and a technical resource for national authorities.
GHAP’s assurance services support clients’ oversight of their contractor, implementing partner, and third-Party vendor relationships, helping to identify fraud, corruption, and failure to deliver agreed services.
GHAP also plays a key role in helping aid agencies and national governments to proactively identify and effectively respond to the trade in illicit medicines and health products.
The trade in Ilicit medicines and health products constitiutes a major global threat. The World Health Organization (WHO) reports that the supply of Substandard and Falsified (SF) medicines and health products in LMICs is 10.5%, undermining public health goals, leading to numerous fatalities and contributing to drug resistant strains of disease. Similarly, where authentic good quality government and donor-funded medicines and health products are stolen from public supply chains, citizens are forced to make purchases from the unregulated commercial sector and are further exposed to the threat of substandard and falsified products. The theft of these commodities may corrode donor confidence and imperil health financing programs. Effective mechanisms to support nationally-led responses to the trade in illicit medicines and health products are therefore crucial to protect public health and provide robust assurance.
GHAP’s full spectrum response helps determine the source, scope, and scale of the problem, and develop tailored solutions to address and resolve issues of concern.
GHAP’s Oversight and Assurance Reviews (OARs™) help clients enhance risk management, compliance program accountability, and oversight of their contracting and service level agreement (SLA) activities.Learn More
Market Assurance Reviews (MARs™) provide stakeholders with risk-based, data-driven assurance of health supply chain integrity. Extensive, focused, and discreet post market surveillance provides donors unprecedented programme performance insight and supports strategic planning for supply chain improvements.Learn More
Where MARs™ identify weaknesses in supply chain integrity, GHAP Supply Chain Assurance Reviews (SCARs™) provide remedial fixes to ensure end-to-end assurance that stakeholder supply chains are conforming without leakage to the highest Good Distribution Practices (GDPs), and that medical products arriving in-country are delivered to patients, with the highest pharmaceutical efficacy.Learn More
Serialization Technical Assistance Resources (STARs™) provide stakeholders with an ongoing resource to drive implementation of national pharmaceutical serialization efforts. No matter the goal – authentication to full traceability – GHAP will help improve efficient roadmap implementation while also ensuring careful attention to stakeholder engagement. Based on important lessons learned in other implementing countries, STARs will help adapt strategies for country context and readiness.Learn More
GHAPs National Engagement Strategy (NES™) strengthens the resilience of health systems via the provision of Technical Assistance (TA) and Capacity Building to National Medical Regulatory Agencies (NMRAs) and other Specialist National Agencies. GHAP provides training on developing an intelligence-led response to the trade in illicit medicines and health products.Learn More
Global Health Assurance Partnership
For further inquiries relating to our services fill out the form.